AMARIN CORP PLC\UK Treasury Stock, Common, Shares
AMARIN CORP PLC\UK (AMRN) had Treasury Stock, Common, Shares of 16.20 million shares as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-07-29
- 2026-06-30: Treasury Stock, Common, Shares 16.20M shares.
- 2026-03-31: Treasury Stock, Common, Shares 15.95M shares.
- 2025-12-31: Treasury Stock, Common, Shares 13.63M shares.
- 2025-09-30: Treasury Stock, Common, Shares 13.63M shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 16.20M shares 10-Q · filed 2026-07-29 |
| 2026-03-31 | 15.95M shares 10-Q · filed 2026-04-29 |
| 2025-12-31 | 13.63M shares 10-Q · filed 2026-07-29 |
| 2025-09-30 | 13.63M shares 10-Q · filed 2025-10-29 |
| 2025-06-30 | 13.31M shares 10-Q · filed 2025-07-30 |
| 2025-03-31 | 12.48M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 10.67M shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 10.73M shares 10-Q · filed 2024-10-30 |
| 2024-06-30 | 10.64M shares 10-Q · filed 2024-07-31 |
| 2024-03-31 | 10.53M shares 10-Q · filed 2024-05-01 |
| 2023-12-31 | 9.32M shares 10-K · filed 2025-03-12 |
| 2023-09-30 | 9.19M shares 10-Q · filed 2023-11-01 |
| 2023-06-30 | 8.96M shares 10-Q · filed 2023-08-02 |
| 2022-12-31 | 7.99M shares 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |